GLP-1 gene therapy triggers 25% weight loss in obese mice, clinical trials planned for next year - Endpoints News
endpts.comSubmitted by endpointsnews6292 in health
One of the biggest problems facing the burgeoning class of weight loss drugs is that people must take them day after day, week after week. When the injections of semaglutide — the ingredient in Ozempic and Wegovy — stop coming, so do the benefits. Lost weight…